MarketPeel
Insider Trading Intelligence
JC

Jane Chung

STRO
PRESIDENT AND COO · SUTRO BIOPHARMA, INC. · CIK 0001872398
FILING MIX · LIFETIME51%/49%
BUYS
31
SELLS
30
TOTAL VALUE
$284.3K
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
0
AVG SELL PX
$4.59
TRADE KIND
SHOWING 61 / 61
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jane Chung, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+48.72%+0.40%+48.32%+48.32%
14d1+100.00%+34.62%+3.34%+31.27%+31.27%
30d1+100.00%+15.38%+1.02%+14.37%+14.37%
60d1+100.00%+27.31%+2.34%+24.97%+24.97%
90d1+100.00%+36.28%+4.30%+31.98%+31.98%
180d1+100.00%+235.77%+3.15%+232.62%+232.62%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
STRO · 0 shares · as of Mar 4, 2026
0155,000310,000465,000620,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 31 buys / 30 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Executive Officer
78821,567Mar 4, 2026Mar 6, 2026View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Executive Officer
282$21.31$6.0K21,285Mar 4, 2026Mar 6, 2026View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Executive Officer
7880Mar 4, 2026Mar 6, 2026View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
175,000175,000Mar 2, 2026Mar 3, 2026View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
40,00040,000Mar 2, 2026Mar 3, 2026View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Executive Officer
2,779$20.55$57.1K20,779Mar 2, 2026Mar 3, 2026View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Executive Officer
7,75023,558Mar 2, 2026Mar 3, 2026View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Executive Officer
7,75023,250Mar 2, 2026Mar 3, 2026View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Executive Officer
1,271$20.47$26.0K15,808Mar 1, 2026Mar 3, 2026View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Executive Officer
2,50017,079Mar 1, 2026Mar 3, 2026View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Executive Officer
688688Mar 1, 2026Mar 3, 2026View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Executive Officer
68814,579Mar 1, 2026Mar 3, 2026View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Executive Officer
2,5005,000Mar 1, 2026Mar 3, 2026View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Executive Officer
2,50014,785Dec 12, 2025Dec 16, 2025View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Executive Officer
2,5005,000Dec 12, 2025Dec 16, 2025View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Executive Officer
894$8.02$7.2K13,891Dec 12, 2025Dec 16, 2025View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Executive Officer
12,500$0.80$10.0K122,850Oct 15, 2025Oct 16, 2025View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Executive Officer
6,708$0.80$5.4K110,350Aug 9, 2025Aug 26, 2025View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Executive Officer
18,7500Aug 9, 2025Aug 26, 2025View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Executive Officer
18,750117,058Aug 9, 2025Aug 26, 2025View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
620,000620,000Apr 4, 2025Apr 8, 2025View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
310,000310,000Apr 4, 2025Apr 8, 2025View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
PRESIDENT AND COO
7,875100,642Mar 4, 2025Mar 6, 2025View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
2,334$1.42$3.3K98,308Mar 4, 2025Mar 6, 2025View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
7,8757,875Mar 4, 2025Mar 6, 2025View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
PRESIDENT AND COO
6,87577,217Mar 1, 2025Mar 4, 2025View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
6,87513,750Mar 1, 2025Mar 4, 2025View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
PRESIDENT AND COO
25,000102,217Mar 1, 2025Mar 4, 2025View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
25,00075,000Mar 1, 2025Mar 4, 2025View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
9,450$1.59$15.0K92,767Mar 1, 2025Mar 4, 2025View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
25,00075,000Dec 1, 2024Dec 3, 2024View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
PRESIDENT AND COO
25,00079,262Dec 1, 2024Dec 3, 2024View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
8,920$2.69$24.0K70,342Dec 1, 2024Dec 3, 2024View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
18,75018,750Aug 9, 2024Aug 13, 2024View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
PRESIDENT AND COO
18,75060,951Aug 9, 2024Aug 13, 2024View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
6,689$3.12$20.9K54,262Aug 9, 2024Aug 13, 2024View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
100,000100,000Mar 5, 2024Mar 7, 2024View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
50,00050,000Mar 5, 2024Mar 7, 2024View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
PRESIDENT AND COO
7,87544,410Mar 4, 2024Mar 6, 2024View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
2,209$4.79$10.6K42,201Mar 4, 2024Mar 6, 2024View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
7,87515,750Mar 4, 2024Mar 6, 2024View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
PRESIDENT AND COO
6,87538,573Mar 1, 2024Mar 5, 2024View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
2,038$4.95$10.1K36,535Mar 1, 2024Mar 5, 2024View →
STRO
SUTRO BIOPHARMA, INC.
SALE
PRESIDENT AND COO
6,87520,625Mar 1, 2024Mar 5, 2024View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
35,00035,000Dec 1, 2023Dec 4, 2023View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
100,000100,000Dec 1, 2023Dec 4, 2023View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Commercial Officer
6,483$4.22$27.4K31,698Aug 9, 2023Aug 11, 2023View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Commercial Officer
18,75038,181Aug 9, 2023Aug 11, 2023View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Commercial Officer
18,75037,500Aug 9, 2023Aug 11, 2023View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Commercial Officer
7,87523,625Mar 3, 2023Mar 7, 2023View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Commercial Officer
7,87522,642Mar 3, 2023Mar 7, 2023View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Commercial Officer
3,211$5.79$18.6K19,431Mar 3, 2023Mar 7, 2023View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
40,00040,000Mar 3, 2023Mar 7, 2023View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
27,50027,500Mar 3, 2023Mar 7, 2023View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Commercial Officer
6,483$6.60$42.8K14,767Aug 9, 2022Aug 10, 2022View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Commercial Officer
18,75056,250Aug 9, 2022Aug 10, 2022View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Commercial Officer
18,75021,250Aug 9, 2022Aug 10, 2022View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
31,50031,500Mar 4, 2022Mar 7, 2022View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
42,00042,000Mar 4, 2022Mar 7, 2022View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
160,000160,000Aug 9, 2021Aug 11, 2021View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
75,00075,000Aug 9, 2021Aug 11, 2021View →
Other insiders · STRO
Loading peer insiders…
About this filer
CIK 0001872398
ROLE
PRESIDENT AND COO
PRIMARY
STRO
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001872398DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback